by Extivita | Apr 12, 2018 | Sudden Sensorineural Hearing Loss
Abstract: This study aimed to compare the efficacy of intratympanic dexamethasone (ITD) therapy and hyperbaric oxygen(HBO) therapy for the salvage treatment of patients with high-frequency sudden sensorineural hearing loss (SSNHL) after the failure of conventional...
by Extivita | Aug 24, 2016 | Cancer
Abstract: Encephalitis caused by anti-N-methyl-d-aspartate receptor (NMDAR) antibodies is the leading cause of immune-mediated encephalitis. There are limited data on intensive care unit (ICU) management of these patients. To identify prognostic factors of good...
by Extivita | Mar 23, 2016 | Stroke
Abstract: Hyperbaric oxygen (HBO₂) therapy is considered to be a generally safe therapy. However, data regarding seizure incidence during HBO₂ therapy as a clinical presentation of central nervous system- (CNS) related oxygen toxicity are conflicting (ranging from...
by Extivita | Mar 23, 2016 | Traumatic Brain Injury (TBI)
Abstract: Hyperbaric oxygen (HBO₂) therapy is considered to be a generally safe therapy. However, data regarding seizure incidence during HBO₂ therapy as a clinical presentation of central nervous system- (CNS) related oxygen toxicity are conflicting (ranging from...
by Extivita | Oct 2, 2015 | Cancer
Abstract: This study identified predictors of high-grade late hematochezia (HH) following 5-fraction gantry-based stereotactic ablative radiation therapy (SABR). Hematochezia data for 258 patients who received 35 to 40 Gy SABR in 5-fractions as part of sequential...
